Cargando…

Plasma Cell Leukemia with Successful Upfront Venetoclax in Combination with Allogeneic Transplantation

Patient: Female, 57-year-old Final Diagnosis: Plasma cell leukemia Symptoms: Epistaxis • gum bleeding and blurred vision Clinical Procedure: Bone marrow trephine biopsy • transplantation Specialty: Hematology OBJECTIVE: Rare disease BACKGROUND: Plasma cell leukemia (PCL) is an aggressive form of pla...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tang, Andy Sing Ong, Asnawi, Asral Wirda Ahmad, Koh, Alex Zhi Yang, Chong, Siew Lian, Liew, Pek Kuen, Selvaratnam, Veena, Fauzi, Alina Md, Lau, Ngee Siang, Tan, Sen Mui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	International Scientific Literature, Inc. 2023
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10009647/ https://www.ncbi.nlm.nih.gov/pubmed/36882990 http://dx.doi.org/10.12659/AJCR.938868

Ejemplares similares

Case Series of Hepatosplenic T-Cell Lymphoma: A Rare and Aggressive Disease
por: Tham, Yea Bing, et al.
Publicado: (2023)

Occult Disseminated Metastatic Breast Carcinoma Presenting as Acquired Thrombotic Thrombocytopenic Purpura
por: Chong, Siew Lian, et al.
Publicado: (2021)

Impact of timely BCR-ABL1 monitoring before allogeneic stem cell transplantation among patients with BCR-ABL1-positive B-acute lymphoblastic leukemia
por: Chong, Siew Lian, et al.
Publicado: (2021)

A Review of Candidate Genes and Pathways in Preeclampsia–An Integrated Bioinformatical Analysis
por: Mohamad, Muhammad Aliff, et al.
Publicado: (2020)

PB2643: EFFICACY OF REDUCED-DOSE EMICIZUMAB IN HEMOPHILIA A WITH INHIBITORS: REAL WORLD EXPERIENCE IN MALAYSIA
por: Tang, Andy Sing Ong, et al.
Publicado: (2023)

Salvage use of venetoclax-based therapy for relapsed AML post allogeneic hematopoietic cell transplantation
por: Joshi, Maansi, et al.
Publicado: (2021)

Venetoclax resistance: mechanistic insights and future strategies
por: Ong, Faustine, et al.
Publicado: (2022)

Venetoclax in Combination with Decitabine for Relapsed T-Cell Acute Lymphoblastic Leukemia after Allogeneic Hematopoietic Cell Transplant
por: Rahmat, Leena T., et al.
Publicado: (2018)

Addition of venetoclax to myeloablative conditioning regimens for allogeneic hematopoietic stem cell transplantation in high-risk AML
por: Cao, Xing-yu, et al.
Publicado: (2023)

Relapsed/Refractory ETP-ALL Successfully Treated With Venetoclax and Nelarabine as a Bridge to Allogeneic Stem Cell Transplant
por: McEwan, Ashley, et al.
Publicado: (2020)

Azacitidine in Combination with Venetoclax Maintenance Post-allogeneic Hematopoietic Stem Cell Transplantation in T Cell Acute Lymphoblastic Leukemia
por: Hassan, Mona Ali, et al.
Publicado: (2023)

A Novel Clinical Decision Support System Using Improved Adaptive Genetic Algorithm for the Assessment of Fetal Well-Being
por: Ravindran, Sindhu, et al.
Publicado: (2015)

DEBATE UPFRONT vs DELAYED TRANSPLANT
por: Gay, F.
Publicado: (2023)

Venetoclax or Ruxolitinib in Pre-Transplant Conditioning Lowers the Engraftment Barrier by Different Mechanisms in Allogeneic Stem Cell Transplant Recipients
por: Davis, Joanne E., et al.
Publicado: (2021)

Efficacy and safety of venetoclax in combination therapy for relapsed acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation
por: Yang, Fan, et al.
Publicado: (2021)

Upfront Daratumumab With Lenalidomide and Dexamethasone for POEMS Syndrome
por: Gavriatopoulou, Maria, et al.
Publicado: (2020)

Surgery for Crohn’s disease: upfront or last resort?
por: Ahmed Ali, U, et al.
Publicado: (2022)

PB2413: SALVAGE THERAPY WITH VENETOCLAX AND A HYPOMETHYLATING AGENT FOR PATIENTS WITH AML RELAPSE AFTER ALLOGENEIC STEM CELL TRANSPLANTATION
por: Shaforostova, Inna, et al.
Publicado: (2023)

Upfront tandem autologous non‐myeloablative allogeneic stem cell transplant in high‐risk multiple myeloma: a long‐term single‐centre experience
por: Nguyen, Phillip C., et al.
Publicado: (2022)

Short-term Outcomes After Upfront Chemotherapy Followed by Curative Surgery in Metastatic Colon Cancer: A Comparison With Upfront Surgery Patients
por: Han, Myung Hyun, et al.
Publicado: (2019)

“Catch Me If You Can”: Recurrent ST-Segment Elevation Myocardial Infarction Due to Aortic Thrombus
por: Cai, Xinzhe James, et al.
Publicado: (2020)

Similar Outcomes in Early-Failure Steroid-Dependent Compared to Upfront Steroid Refractory Acute Graft-Versus-Host Disease Following Allogeneic Hematopoietic Cell Transplant
por: Patel, Dilan A., et al.
Publicado: (2021)

Electrolyte disorders secondary to venetoclax
por: van der Lubbe, Nils, et al.
Publicado: (2020)

Mechanisms of venetoclax resistance and solutions
por: Liu, Jiachen, et al.
Publicado: (2022)

Upfront Stereotactic Radiosurgery for Pineal Parenchymal Tumors in Adults
por: Park, Jong Hoon, et al.
Publicado: (2015)

AL AMYLOIDOSIS UPFRONT TREATMENT AND CURRENT AND FUTURE STUDIES
por: Kastritis, E.
Publicado: (2023)

Targeting Acute Myeloid Leukemia with Venetoclax; Biomarkers for Sensitivity and Rationale for Venetoclax-Based Combination Therapies
por: Griffioen, Mila S., et al.
Publicado: (2022)

Venetoclax retreatment of patients with chronic lymphocytic leukemia after a previous venetoclax-based regimen
por: Thompson, Meghan C., et al.
Publicado: (2022)

P646: VENETOCLAX RETREATMENT AFTER MRD-GUIDED VENETOCLAX +/- IBRUTINIB: THE IMPROVE STUDY COHORT
por: Scarfò, Lydia, et al.
Publicado: (2023)

HEMATOPOIETIC STEM CELL TRANSPLANT IN AGGRESSIVE T AND NK/T CELL LYMPHOMA - ROLE OF UPFRONT AUTOLOGOUS TRANSPLANT IN NODAL PERIPHERAL T-CELL LYMPHOMA
por: Cheng Kiat Ng, Lawrence, et al.
Publicado: (2021)

LHCb : potential for Kaon physics with a full upfront reconstruction
por: Bettler, Marc Olivier
Publicado: (2016)

Health professionals for global health: include dental personnel upfront!
por: Preet, Raman
Publicado: (2013)

Upfront surgery of small intestinal neuroendocrine tumors. Time to reconsider?
por: Daskalakis, Kosmas, et al.
Publicado: (2018)

Upfront Enzyme Replacement via Erythrocyte Transfusions for PNP Deficiency
por: Eichinger, Anna, et al.
Publicado: (2021)

Ogilvie’s syndrome—is there a cutoff diameter to proceed with upfront surgery?
por: Joechle, Katharina, et al.
Publicado: (2022)

Early Recurrence after Upfront Surgery for Pancreatic Ductal Adenocarcinoma
por: Nappo, Gennaro, et al.
Publicado: (2023)

Development of venetoclax for therapy of lymphoid malignancies
por: Zhu, Huayuan, et al.
Publicado: (2017)

Venetoclax: evidence to date and clinical potential
por: Juárez-Salcedo, Luis Miguel, et al.
Publicado: (2019)

Refractory Autoimmune Cytopenias Treated With Venetoclax
por: Gordon, Max J., et al.
Publicado: (2019)

Venetoclax: Various toxicities: case report
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_bemt6oho216m5nca6sdljsolg3